# BARX1

## Overview
The BARX1 gene encodes the BARX homeobox 1 protein, a transcription factor characterized by a homeodomain, which is crucial for its role in transcriptional regulation. This protein is involved in various developmental processes, particularly in craniofacial and tooth development, due to its expression in neural crest-derived mesenchyme (Gould2000Cloning). BARX1 functions as both a transcriptional activator and repressor, influencing gene expression by binding to specific DNA sequences within the nucleus (Gould2000Cloning). Its expression in multiple tissues, including the testis and heart, underscores its diverse biological roles (Gould2000Cloning). Additionally, BARX1 has been implicated in oncogenic processes, particularly in cancers such as non-small cell lung cancer and clear cell renal cell carcinoma, where it contributes to tumor progression and poor prognosis (Sun2021Transcription; Zhang2023ZFP36). The gene's evolutionary conservation highlights its fundamental importance in developmental biology (Gould2000Cloning).

## Function
The BARX1 gene encodes a transcription factor that plays a significant role in transcriptional regulation within the nucleus of human cells. The BARX1 protein contains a homeodomain, a highly conserved proline/serine/threonine domain, and a polyalanine stretch, which suggests its function as a transcriptional activator or repressor, or potentially both (Gould2000Cloning). The presence of a putative nuclear localization signal supports its role in the nucleus, where it likely influences gene expression by binding to DNA and modulating the transcription of target genes (Gould2000Cloning).

BARX1 is expressed in various tissues, including the testis, heart, and craniofacial tissues, indicating its involvement in the development and function of these areas (Gould2000Cloning). In particular, its expression in developing teeth and craniofacial mesenchyme of neural crest origin suggests a role in craniofacial development and tooth formation (Gould2000Cloning). The gene's expression pattern aligns with its potential involvement in human disorders related to craniofacial structures, although no disease-causing mutations have been identified in BARX1 (Gould2000Cloning). The conservation of BARX1 across species highlights its fundamental role in developmental processes (Gould2000Cloning).

## Clinical Significance
The BARX1 gene has been implicated in several cancers due to its role in transcription regulation. In clear cell renal cell carcinoma (ccRCC), BARX1 is part of a six-transcription factor panel that predicts poor overall survival. High expression of BARX1 is associated with increased cell proliferation and epithelial-mesenchymal transition, contributing to tumor progression and poor prognosis in ccRCC patients (Sun2021Transcription).

In non-small cell lung cancer (NSCLC), BARX1 is upregulated in lung adenocarcinoma and squamous cell carcinoma, correlating with poor survival rates. The RNA-binding protein ZFP36 normally destabilizes BARX1 mRNA, but its loss leads to BARX1 upregulation, promoting proliferation, migration, and invasion of NSCLC cells. This dysregulation activates oncogenes such as CDC20 and MMP-9, enhancing cancer progression (Zhang2023ZFP36).

In esophageal squamous cell carcinoma (ESCC), BARX1 expression is significantly higher in tumor tissues. A genetic variant, rs11789015, is associated with decreased BARX1 expression and reduced ESCC risk, suggesting BARX1's role in cancer susceptibility (Yan2018An).

BARX1 is also linked to infantile hypertrophic pyloric stenosis (IHPS), with its expression crucial for gastrointestinal development. Alterations in BARX1 expression may contribute to congenital malformations and increased cancer risk (Fadista2018Genomewide).

## Interactions
BARX1 is a transcription factor that participates in various interactions with nucleic acids and proteins, influencing gene expression and cellular processes. In non-small cell lung cancer (NSCLC), BARX1 acts as an oncogenic transcription factor by binding directly to the promoters of several oncogenes, including CDC20, CDC45, TRIM37, and MMP-9, thereby activating their expression. This binding suggests a direct interaction with specific DNA sequences, promoting malignant phenotypes such as increased proliferation, migration, and invasion of cancer cells (Zhang2023ZFP36).

In the context of chondrogenesis, BARX1 interacts with the protein Nkx3.2, disrupting its interaction with IkB, which leads to the attenuation of NF-kB activation. This interaction highlights BARX1's role as a negative regulator of chondrocyte survival, independent of its transcriptional activity (Choi2019Barx1).

In gastrointestinal stromal tumors (GIST), BARX1, along with HAND1, is involved in transcriptional programs that determine malignancy. Although specific physical interactions with other proteins or nucleic acids in GIST are not detailed, BARX1's role in transcriptional regulation is emphasized (Hemming2021HAND1).


## References


[1. (Fadista2018Genomewide) João Fadista, Line Skotte, Frank Geller, Jonas Bybjerg-Grauholm, Sanne Gørtz, Paul A Romitti, Michele Caggana, Denise M Kay, Hans Matsson, Heather A Boyd, David M Hougaard, Agneta Nordenskjöld, James L Mills, Mads Melbye, and Bjarke Feenstra. Genome-wide meta-analysis identifiesbarx1andeml4-mta3as new loci associated with infantile hypertrophic pyloric stenosis. Human Molecular Genetics, 28(2):332–340, October 2018. URL: http://dx.doi.org/10.1093/hmg/ddy347, doi:10.1093/hmg/ddy347. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddy347)

[2. (Hemming2021HAND1) Matthew L. Hemming, Shannon Coy, Jia-Ren Lin, Jessica L. Andersen, Joanna Przybyl, Emanuele Mazzola, Amr H. Abdelhamid Ahmed, Matt van de Rijn, Peter K. Sorger, Scott A. Armstrong, George D. Demetri, and Sandro Santagata. Hand1 and barx1 act as transcriptional and anatomic determinants of malignancy in gastrointestinal stromal tumor. Clinical Cancer Research, 27(6):1706–1719, January 2021. URL: http://dx.doi.org/10.1158/1078-0432.CCR-20-3538, doi:10.1158/1078-0432.ccr-20-3538. This article has 19 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1078-0432.CCR-20-3538)

[3. (Choi2019Barx1) S.-W. Choi, H.-J. Choi, and D.-W. Kim. Barx1 regulates chondrocyte survival by modulating nkx3.2-mediated nf-kb activation. Osteoarthritis and Cartilage, 27:S195, April 2019. URL: http://dx.doi.org/10.1016/j.joca.2019.02.300, doi:10.1016/j.joca.2019.02.300. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.joca.2019.02.300)

[4. (Yan2018An) Caiwang Yan, Yong Ji, Tongtong Huang, Fei Yu, Yong Gao, Yayun Gu, Qi Qi, Jiangbo Du, Juncheng Dai, Hongxia Ma, and Guangfu Jin. An esophageal adenocarcinoma susceptibility locus at 9q22 also confers risk to esophageal squamous cell carcinoma by regulating the function of barx1. Cancer Letters, 421:103–111, May 2018. URL: http://dx.doi.org/10.1016/j.canlet.2018.02.019, doi:10.1016/j.canlet.2018.02.019. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2018.02.019)

[5. (Sun2021Transcription) Guoliang Sun, Yue Ge, Yangjun Zhang, Libin Yan, Xiaoliang Wu, Wei Ouyang, Zhize Wang, Beichen Ding, Yucong Zhang, Gongwei Long, Man Liu, Runlin Shi, Hui Zhou, Zhiqiang Chen, and Zhangqun Ye. Transcription factors barx1 and dlx4 contribute to progression of clear cell renal cell carcinoma via promoting proliferation and epithelial–mesenchymal transition. Frontiers in Molecular Biosciences, May 2021. URL: http://dx.doi.org/10.3389/fmolb.2021.626328, doi:10.3389/fmolb.2021.626328. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2021.626328)

[6. (Gould2000Cloning) Douglas B. Gould and Michael A. Walter. Cloning, characterization, localization, and mutational screening of the human barx1 gene. Genomics, 68(3):336–342, September 2000. URL: http://dx.doi.org/10.1006/GENO.2000.6307, doi:10.1006/geno.2000.6307. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/GENO.2000.6307)

[7. (Zhang2023ZFP36) Tongjia Zhang, Lizhen Qiu, Jiashun Cao, Qiu Li, Lifan Zhang, Guoshun An, Juhua Ni, Hongti Jia, Shuyan Li, and Kailong Li. Zfp36 loss-mediated barx1 stabilization promotes malignant phenotypes by transactivating master oncogenes in nsclc. Cell Death &amp; Disease, August 2023. URL: http://dx.doi.org/10.1038/s41419-023-06044-z, doi:10.1038/s41419-023-06044-z. This article has 1 citations.](https://doi.org/10.1038/s41419-023-06044-z)